DYAI
DYAI
NASDAQ · Biotechnology

Dyadic International Inc

$0.68
-0.02 (-3.21%)
As of Mar 29, 10:53 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +4,709.2% upside
Low Target $20.70
Average Target $32.64
High Target $34.69
Current Price $0.68
Current
$0.68
Target
$32.64
$20.70 $32.64 avg $34.69
Scenario Analysis
Bear Case
$20.70
2,949.9%
Low target
Base Case
$32.64
+4,709.2%
Avg target
Bull Case
$34.69
+5,011.2%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$1.45
-53.2% from high
52-Week Low
$0.65
+3.7% from low
Target vs 52W High
$32.64
+2,151.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%